1. Home
  2. CUB vs JSPR Comparison

CUB vs JSPR Comparison

Compare CUB & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUB
  • JSPR
  • Stock Information
  • Founded
  • CUB 2024
  • JSPR 2018
  • Country
  • CUB United States
  • JSPR United States
  • Employees
  • CUB N/A
  • JSPR N/A
  • Industry
  • CUB
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CUB
  • JSPR Health Care
  • Exchange
  • CUB NYSE
  • JSPR Nasdaq
  • Market Cap
  • CUB 322.0M
  • JSPR 85.8M
  • IPO Year
  • CUB 2024
  • JSPR N/A
  • Fundamental
  • Price
  • CUB $10.46
  • JSPR $6.70
  • Analyst Decision
  • CUB
  • JSPR Strong Buy
  • Analyst Count
  • CUB 0
  • JSPR 9
  • Target Price
  • CUB N/A
  • JSPR $59.25
  • AVG Volume (30 Days)
  • CUB 50.4K
  • JSPR 386.0K
  • Earning Date
  • CUB 08-22-2025
  • JSPR 08-12-2025
  • Dividend Yield
  • CUB N/A
  • JSPR N/A
  • EPS Growth
  • CUB N/A
  • JSPR N/A
  • EPS
  • CUB 0.34
  • JSPR N/A
  • Revenue
  • CUB N/A
  • JSPR N/A
  • Revenue This Year
  • CUB N/A
  • JSPR N/A
  • Revenue Next Year
  • CUB N/A
  • JSPR N/A
  • P/E Ratio
  • CUB $31.24
  • JSPR N/A
  • Revenue Growth
  • CUB N/A
  • JSPR N/A
  • 52 Week Low
  • CUB $9.96
  • JSPR $3.13
  • 52 Week High
  • CUB $10.61
  • JSPR $26.05
  • Technical
  • Relative Strength Index (RSI)
  • CUB N/A
  • JSPR 73.64
  • Support Level
  • CUB N/A
  • JSPR $5.35
  • Resistance Level
  • CUB N/A
  • JSPR $5.72
  • Average True Range (ATR)
  • CUB 0.00
  • JSPR 0.51
  • MACD
  • CUB 0.00
  • JSPR 0.12
  • Stochastic Oscillator
  • CUB 0.00
  • JSPR 89.77

About CUB LIONHEART HOLDINGS

Lionheart Holdings is a blank check company.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: